Indian Prime Minister Narendra Modi on Saturday said there are requests from Bangladesh, Myanmar, Qatar and Bhutan for clinical trials of Covid-19 vaccine.

A Chinese COVID-19 vaccine candidate based on the inactivated whole SARS-CoV-2 virus is safe and elicits an antibody response, according to the findings from a small early-phase randomised clinical trial published Thursday in The Lancet Infectious Diseases journal.